Global Brain Imaging Devices Market Report 2032

Global brain imaging devices market is projected to witness a CAGR of 7.61% during the forecast period 2025-2032, growing from USD 4.98 billion in 2024 to USD 8.95 billion in 2032. The market’s growth can be attributed to the increasing prevalence of neurological diseases, rising investments in product innovations and research and development activities, and supportive regulatory frameworks and policies. As per the estimates of the World Health Organization (WHO) over 1 in 3 people across the globe are affected by neurological conditions. The increasing incidences of neurological disorders can be attributed to the rapid expansion of the geriatric population and increasing lifestyle changes.

Continuous innovations and rapid advancements in brain imaging technologies along with integration of machine learning and artificial intelligence (AI) with brain imaging devices are allowing early disease detection. AI-powered tools are being used to automate image interpretation, detect subtle changes invisible to the human eye, and predict disease outcomes based on large datasets. These technologies significantly reduce the workload of healthcare professionals and are boosting diagnostic throughput in busy clinical environments. Furthermore, cloud-based imaging solutions allow remote viewing, tele-neurology consultations, and real-time collaboration, which are especially useful in rural regions. Advancements in wearable EEG devices and portable MRI units are ease of use and improving mobility, increasing user convenience and supporting the market’s expansion.

Click – https://www.marketsandata.com/industry-reports/brain-imaging-devices-market

Increasing Focus on Research and Development Boosts Market Growth

Research and development activities are fueling innovations and leading to the development of advanced imaging technologies including functional imaging and high-resolution MRIs, among others. Such innovations allow healthcare professionals to monitor the progression of neurological diseases while meeting the rising requirements for non-invasive and precise diagnostic solutions. Additionally, increasing research efforts are also aiding companies in gaining approvals from different regulatory bodies for their products and technologies, further incentivizing them to invest in product innovation. For instance, in May 2025, Hyperfine, Inc. secured clearance from the United States Food and Drug Administration (US FDA) for the latest version of its Swoop system’s Optive AI software. The software is able to refine each stage involved in image processing, from postprocessing, noise cancellation, and reconstruction, to image acquisition. Furthermore, the integration of AI-driven enhancements is reducing scan time, streamlining workflow, and supporting rapid clinical decision making. Such advancements are broadening the utility and reach of brain imaging devices, propelling the market’s growth.

Rising Prevalence of Neurological Diseases Supports Market Expansion

Due to the expansion of the geriatric population, the incidences of age-related cognitive disorders including Parkinson’s disease and Alzheimer’s are rapidly increasing. As per the estimates of the Parkinson’s Foundation, over 10 million people across the world are living with Parkinson’s disease. Brain imaging is essential for diagnosing, monitoring, and managing such conditions as they often require long-term medical oversight, thus bolstering the market’s demand. By integrating functional imaging techniques, such as fMRI and PET, it has become possible to observe not just the brain’s structure, but also its metabolic and functional activity, enabling physicians to track disease progression in a more precise manner and tailor treatment strategies accordingly. The continued push toward precision medicine and personalized treatments are bolstering the requirement for detailed, patient-specific brain maps, thus augmenting the requirement for advanced brain imaging technologies.

Devices Account for Significant Share of the Market

Devices, in particular MRIs, hold a major share of the brain imaging devices market. This dominance can be attributed to their ability to provide detailed and high-resolution functional and anatomical images of the brain. The superior image quality provided by MRIs allows clinicians to monitor disease progression and detect subtle abnormalities more effectively. Technological advancements, including integration of AI for conducting image analysis are providing improved diagnostic accuracy, expanding the accessibility of MRI technology, and reducing scan times.

In order to further increase physician and patient convenience, the key players of the market are focusing on introducing new products. For instance, in March 2024, FUJIFILM India Private Limited launched the Echelon Synergy MRI Machine at its CT and MRI User Conclave held at Mumbai, India. The system ensures fast exam times, low power consumption, and features sitting flexibility. Such launches are improving patient convenience and positively influencing the market’s expansion.

North America Holds Major Market Share

The region’s dominance in the market is supported by the high awareness about neurological conditions, easy acceptance of advanced diagnostic technologies, strong presence of leading market players, and high investments in research and development activities. As per the estimates of Alzheimer’s Association, over 7 million people in America are living with Alzheimer’s. The number is estimated to increase to 13 million by 2050.

Additionally, the increasing popularity and availability of compact and portable brain imaging devices in the region is enhancing patient convenience and accessibility, making it easier for medical professionals to conduct diagnostic procedures in various settings, including remote locations. Such innovations are improving healthcare delivery across North America and supporting the market’s expansion. Increasing public fundings and government initiatives towards neuroscience research, including the BRAIN Initiative are also supporting the market’s expansion in countries such as the United States.

Download Free Sample Report

Impact of the U.S. Tariff on Global Brain Imaging Devices Market

The recently launched tariffs are affecting imports from major manufacturing hubs including, Mexico, China, and the European Union and have imposed significant economic pressure on healthcare providers and medical device manufacturers and strains on supply chains. The escalation in tariffs is forcing various companies to seek alternative suppliers and reassess their sourcing strategies and focus on enhancing their domestic manufacturing capabilities. The increasing financial strains on medical device companies could potentially lead to reduced investments in research and development activities, slowing down innovations in brain imaging technologies.

Report Scope

“Global Brain Imaging Devices Market Assessment, Opportunities and Forecast, 2018-2032F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of global brain imaging devices market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between 2025 and 2032. Additionally, the report profiles the leading players in the industry, mentioning their respective market share, business models, competitive intelligence, etc.

Contact

Mr. Vivek Gupta
5741 Cleveland street,
Suite 120, VA beach, VA, USA 23462
Tel: +1 (757) 343–3258
Email: info@marketsandata.com
Website: https://www.marketsandata.com